Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
bevacizumab (avastin) (1 trial)
cisplatin (platinol) (1 trial)
paclitaxel (taxol) (1 trial)
Carcinoma, Ovarian Epithelial (Phase 2)
Ovarian Neoplasms (Phase 2)
Uterine Cervical Neoplasms (Phase 2)
Trials (2 total)
Trial APIs (3 total)